Clinical Trial Update: Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the combination of panobinostat and letrozole in metastatic breast cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• Farydak (panobinostat)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-27